Liver cirrhosis develops when repeated injury to the liver triggers a buildup of scar tissue that gradually replaces healthy cells. The most common causes are long-term alcohol use, fatty liver disease tied to metabolic factors, and chronic viral hepatitis, though a range of genetic, autoimmune, and other conditions can also drive the process. Globally, cirrhosis-related deaths reached over 1.4 million in 2021, a 39.5% increase from 1990.
How Scarring Actually Happens
Regardless of the cause, cirrhosis follows a common biological pathway. The liver contains specialized cells that normally sit quietly between other liver structures, storing vitamin A. When the liver is injured, whether by alcohol, a virus, or fat buildup, inflammatory signals activate these cells and transform them into a type that produces large amounts of collagen, the tough protein found in scar tissue. These activated cells are responsible for roughly 80% of the fibrous collagen in a scarred liver.
At first, the scarring is mild and the liver can still compensate. Over years or decades of ongoing damage, collagen accumulates, blood flow through the liver gets disrupted, and healthy tissue is progressively replaced. This is when cirrhosis sets in. The critical point: cirrhosis is not a single event but the end stage of a long process of fibrosis that can take anywhere from several years to several decades depending on the cause and the person.
Alcohol Use
Heavy drinking over many years is one of the most well-established causes of cirrhosis. A standard drink contains about 12 grams of pure alcohol, roughly equivalent to one 12-ounce beer, one 5-ounce glass of wine, or one 1.5-ounce shot of liquor. The risk threshold differs sharply by sex. Women face a measurably increased risk at just one to two drinks per day, while men generally don’t show elevated risk at that level.
At five or more drinks per day, the risk climbs dramatically for both sexes. Women drinking five to six standard drinks daily have roughly 12 times the risk of cirrhosis compared to long-term abstainers, and at seven or more drinks daily the risk jumps to about 25 times higher. Men drinking at those levels face roughly 4 to 7 times the risk. The large gap between men and women likely reflects differences in how the body metabolizes alcohol, body composition, and hormonal factors. Not every heavy drinker develops cirrhosis, but the dose-response relationship is steep, and years of sustained drinking compound the damage.
Fatty Liver Disease and Metabolic Factors
Fat buildup in the liver that isn’t caused by alcohol, often called nonalcoholic fatty liver disease, has become increasingly common alongside rising rates of obesity and type 2 diabetes. Most people with simple fatty liver never develop serious problems. The concern is when the fat triggers chronic inflammation, a condition sometimes called nonalcoholic steatohepatitis. Even then, only about 3 to 5% of people with biopsy-confirmed inflammatory fatty liver disease progress to cirrhosis, liver failure, or liver cancer.
The mechanisms involve several overlapping metabolic problems. Excess sugar intake, particularly fructose, promotes the liver’s production of new fat. Insulin resistance makes it harder for the liver to regulate fat storage and export. Over time, the combination of excess fat, inflammation, and oxidative stress damages liver cells and kicks off the same scarring cascade seen with other causes. Weight loss, improved blood sugar control, and reduced fructose intake can slow or even reverse the fat accumulation and inflammation before cirrhosis develops.
Chronic Hepatitis B and C
Chronic infection with hepatitis B or hepatitis C is a leading cause of cirrhosis worldwide. For hepatitis B, approximately 15 to 25% of people with chronic infection develop serious liver disease, including cirrhosis, liver failure, or liver cancer. The progression typically unfolds over decades, with the virus causing ongoing low-grade inflammation that gradually drives fibrosis.
Chronic hepatitis C follows a similar trajectory. Left untreated, many patients develop progressive fibrosis over 20 to 30 years. The good news is that antiviral treatment can halt and even reverse this damage. In one study, 82% of hepatitis C patients who achieved a lasting cure after treatment saw their fibrosis scores decrease over a five-year follow-up. For hepatitis B, studies of antiviral therapy have shown that 73 to 74% of patients with cirrhosis at the start of treatment were no longer classified as cirrhotic after three to five years of therapy.
Autoimmune Liver Diseases
In some people, the immune system attacks the liver’s own tissue. Two conditions stand out as important causes of cirrhosis.
Primary biliary cholangitis involves immune cells, primarily a type of white blood cell, destroying small bile ducts inside the liver. As these ducts deteriorate, bile acids that would normally be secreted become trapped in liver tissue, acting as toxins that fuel further inflammation and scarring. This condition predominantly affects women.
Primary sclerosing cholangitis targets the medium and large bile ducts both inside and outside the liver. Chronic inflammation causes progressive scarring and narrowing of these ducts, eventually leading to blockages. The ongoing bile duct destruction drives fibrosis that can progress to cirrhosis. This condition is strongly associated with inflammatory bowel disease. Autoimmune hepatitis, a third category, directly attacks liver cells. With treatment, fibrosis scores improved in about 53% of patients in one study spanning just over five years.
Genetic and Inherited Conditions
Several inherited disorders cause the liver to accumulate substances it cannot properly process, leading to progressive damage.
- Hemochromatosis causes the body to absorb and store too much iron. The excess iron deposits in liver tissue, generating oxidative stress that damages cells and promotes fibrosis. It is one of the most common genetic liver diseases. When treated early with regular blood removal to reduce iron levels, fibrosis can regress. In one study, 69% of patients with advanced pre-cirrhotic fibrosis and 35% of those with established cirrhosis showed significant improvement.
- Wilson’s disease disrupts the body’s ability to metabolize copper, leading to abnormal copper accumulation in the liver and brain. The copper deposits cause direct cellular damage and inflammation that can progress to cirrhosis if untreated.
- Alpha-1 antitrypsin deficiency is one of the most common genetic liver diseases in both children and adults. The liver produces a misfolded version of a protective protein that gets stuck inside liver cells rather than being released into the bloodstream. The accumulated abnormal protein triggers cell damage and scarring over time.
Other Contributing Causes
Bile duct obstruction from gallstones, tumors, or surgical complications can cause bile to back up into the liver, producing inflammation and eventual fibrosis. Chronic heart failure can lead to long-term liver congestion, sometimes called cardiac cirrhosis, where persistently elevated pressure in the veins draining the liver causes cell death and scarring. Certain medications taken over long periods, as well as exposure to environmental toxins, can also contribute. In some cases, no identifiable cause is found, a situation historically called cryptogenic cirrhosis, though many of these cases are now believed to be related to undiagnosed fatty liver disease.
Compensated vs. Decompensated Cirrhosis
One reason cirrhosis is often diagnosed late is that the liver is remarkably good at functioning despite significant scarring. In compensated cirrhosis, the asymptomatic stage, you may have no noticeable symptoms at all. There is no fluid buildup in the abdomen, no yellowing of the skin, no bleeding from swollen veins in the esophagus, and no confusion from toxin buildup in the brain.
Decompensated cirrhosis is when these complications appear. The hallmarks are ascites (fluid in the abdomen), jaundice (yellowing of the skin and eyes), variceal hemorrhage (bleeding from enlarged veins in the esophagus or stomach), and hepatic encephalopathy (confusion and cognitive changes caused by toxins the damaged liver can no longer filter). The transition from compensated to decompensated cirrhosis marks a significant shift in prognosis and typically changes the treatment approach dramatically.
Can Cirrhosis Be Reversed?
For a long time, cirrhosis was considered a one-way street. That view has changed. Fibrosis is now understood as a dynamic, bidirectional process. Early-stage fibrosis, before the scar tissue becomes heavily cross-linked and new blood vessel networks form within it, can revert to nearly normal liver architecture when the underlying cause is removed.
Even established cirrhosis has shown measurable reversal in clinical studies across multiple causes. The key variable is whether the source of injury can be eliminated or controlled. For alcoholic liver disease, abstinence significantly improves outcomes: five-year survival rates are roughly 75% for those who stop drinking compared to 50% for those who continue. For viral hepatitis, antiviral cures produce documented fibrosis regression in the majority of patients. For autoimmune and metabolic liver diseases, targeted treatment can slow, halt, or partially reverse scarring.
That said, the more advanced the cirrhosis and the longer it has been present, the less capacity the liver has for recovery. Decompensated cirrhosis with extensive scarring and architectural distortion is far less likely to reverse meaningfully, and liver transplantation may become the only option for restoring function.